Creation of innovative technology-based companies in the public health system 22 Nov, 2013

Visto 1878 veces

Creation of innovative technology-based companies in the public health system

The Institute of Biomedical Research of Vigo (IBIV), within BIOCAPS´ Project Framework, has celebrated the “1st International Congress on Biomedical Research & Innovation” on the 21st and 22nd of November 2013 in Vigo, Spain. The event highlights the most important R&D aspects related to the Biomedical Research and Innovation in the following fields: Neurological sciences and rare diseases; Infectious diseases, Inflammation and Immunity; Endocrinology, Metabolism and Nutrition; Biomaterials, Tissue engineering and Regenerative Medicine; New tools in diagnosis and therapy; Ageing and cardiovascular diseases; and Biomedical Innovation. In each field, renowned researchers expose their studies. The congress is expected to become a point of reference for Biomedical Research and Innovation, transmitting scientific perspective and awareness among scientists, public bodies, enterprises and the society.

Jaume Reventós
Research Unit in Biomedicine and Translational and Pediatric Oncology, Vall d’Hebron Research Institute and Hospital, Barcelona